insights_auto
Por que EVGN caiu 2,43%?
Saiba maischevron_right
EVGN:NASDAQ
Evogene Ltd
US$ 0,42
arrow_downward
-2,43%(-0,011) 1D
US$ 0,41
arrow_downward
-4,54% (-0,019)todayPré-abertura
Fechado: 2 de out., 16:00:01 GMT-4 · USD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para EVGN…
Abrir
US$ 0,41
Alta
US$ 0,45
Baixa
US$ 0,41
Valor de mercado
6,65 mi
Volume médio
2,57 mi
Volume
57,50 mil
Alto — 52 sem
US$ 1,50
Baixo — 52 sem
US$ 0,35
LPA
-US$ 0,91
Beta
1,44
Ações em circulação
15,80 mi
Nº de funcionários
52
Abrir
US$ 0,41
Alta
US$ 0,45
Baixa
US$ 0,41
Valor de mercado
6,65 mi
Volume médio
2,57 mi
Volume
57,50 mil
Alto — 52 sem
US$ 1,50
Baixo — 52 sem
US$ 0,35
LPA
-US$ 0,91
Beta
1,44
Ações em circulação
15,80 mi
Nº de funcionários
52
Notícias
De fontes da web e parceiros de notícias
AD HOC NEWS
·
há 58 minutos
Evogene stock fell 2.43 percent as Nasdaq deadline moved
Perfil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Sobre Evogene Ltd